Thats not a sustainable economic model. Hims saw its revenue skyrocket after the FDA opened the doors to compounded weight-loss drugs
We found that especially PSPH V116I mutant cells accelerated their 2D growth under physiological (low) glucose conditions (Figure S7B, p = 0.0013 for PSPH V116I ), and both GBM isogenic models showed a 2-fold increase in clonogenic capacity in 3D alvetex assays under low glucose conditions (Fig
Rabbit anti-GLP-1R antibody, mouse anti-glial fibrillary acidic protein (GFAP) and mouse anti-alpha smooth muscle actin ( -SMA) were from Abcam PLC (Cambridge, UK), Goat anti-type I collagen antibody from Southern Biotechnology (Birmingham, AL, USA), rabbit antibody against glyceraldehydes-3-phosphate dehydrogenase (GAPDH) from Trevigen (Gaithersburg, MD, USA) and anti-rabbit IgG Alexa488-conjugated antibody, anti-mouse-IgG-Alexa555-conjugated antibody, anti-goat-IgG-Alexa350-conjugated antibody and Hoechst33342 were from Invitrogen (Carlsbad, CA, USA)
Binding of IGF1 to either of the two equivalent binding sites in IGF1R triggers the structural rearrangement in half of the apo IGF1R dimer
